STAT3 and hepatocellular carcinoma: Concurrently, JAK1/2 inactivation disrupts IFN-γ signaling, reducing T cell infiltration[79], whereas PTEN-STAT3 dysregulation promotes STAT3 nuclear translocation (prevalent in 60% of HCC patients), which inhibits T cell cytotoxicity and is correlated with poor prognosis[80].